Killing Me Unsoftly: Causes and Mechanisms of Arterial Stiffness.
Alicia N Lyle, Uwe Raaz
https://pubmed.ncbi.nlm.nih.gov/28122777/Actively Recruiting
Led by University of Leipzig · Updated on 2025-12-05
80
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the effects of cross-sex hormone therapy on several interconnected body systems in people undergoing this treatment for gender dysphoria. The study focuses on glucose and lipid metabolism, energy balance, eating behavior, functional brain networks related to eating, and the cardiovascular system. It also explores how the gut and oral microbiomes and metabolomes relate to these systems to better understand risks of overeating, obesity, insulin resistance, and heart disease. This observational study compares individuals starting cross-sex hormone therapy with a control group not receiving hormone treatment. Patients receive testosterone or estradiolantiandrogens according to medical guidelines, and no invasive procedures are performed. Measurements are taken before starting therapy and at several time points over five years, including assessments at 3, 6, 12, 24, and 60 months. Controls matched by age, BMI, and health status are included for comparison. Participants undergo detailed evaluations including physical exams, blood tests, body composition analysis, energy expenditure measurement, ultrasound of vessels, food intake tests, taste and smell assessments, and microbiome sample collection. Data on hormone levels, metabolism, cardiovascular health, and eating behavior are collected repeatedly. Safety monitoring includes non-invasive procedures and questionnaires. The study aims to follow participants for up to five years to understand long-term effects of hormone therapy on these physiological systems.
CONDITIONS
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
H
Haiko Schloegl, MD
S
Sascha Heinitz, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Leipzig
Lead Sponsor
Göteborg University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) to assess eligibility and obtain informed consent
Duration - 1 day
Participants undergo a comprehensive baseline assessment before starting cross-sex hormone therapy or no therapy, including medical history, physical examination, body composition, energy expenditure, cardiovascular ultrasound, food intake tests, sensory perception tests, and microbiome sampling.
1 visit (in-person) for baseline measurements and assessments
Duration - Up to 5 years
Participants undergoing cross-sex hormone therapy receive hormone treatment and are monitored with repeated assessments to investigate effects on metabolism, eating behavior, energy balance, cardiovascular system, and microbiomes.
6 visits over 5 years at 3 months, 6 months, 12 months, 2 years, and 5 years after starting therapy
Duration - Up to 5 years
Participants not undergoing cross-sex hormone therapy are monitored with the same assessments over time to compare changes with treated participants.
6 visits over 5 years matching the treatment group schedule
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Alicia N Lyle, Uwe Raaz
https://pubmed.ncbi.nlm.nih.gov/28122777/Janett Püschel, Konstanze Miehle, Karsten Müller...
https://pubmed.ncbi.nlm.nih.gov/30539782/Annette Horstmann, Franziska P Busse, David Mathar...
https://pubmed.ncbi.nlm.nih.gov/21713067/Annabelle Santos Volgman, C Noel Bairey Merz, Neelum T Aggarwal...
https://pubmed.ncbi.nlm.nih.gov/31549581/Jang-Young Kim, Jeong Bae Park, Dong Soo Kim...
https://pubmed.ncbi.nlm.nih.gov/26587439/Ethan Butler, Melissa Chin, Anders Aneman
https://pubmed.ncbi.nlm.nih.gov/27876185/Thais Coutinho, Barry A Borlaug, Patricia A Pellikka...
https://pubmed.ncbi.nlm.nih.gov/23122799/Haiko Schlögl, Karsten Müller, Annette Horstmann...
https://pubmed.ncbi.nlm.nih.gov/27207511/D M Garner, P E Garfinkel
https://pubmed.ncbi.nlm.nih.gov/472072/Nienke M Nota, Chantal M Wiepjes, Christel J M de Blok...
https://pubmed.ncbi.nlm.nih.gov/30776252/University of Leipzig
Lead Sponsor
Göteborg University
Collaborating Sponsor